hero section gradient
15 handpicked stocks

Friends in High Places

This collection features companies that strategically invest in political lobbying to influence policy and secure their competitive edge. Our analysts have carefully selected firms that leverage government relationships to create regulatory advantages and sustained profitability.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise summary and investor takeaways for the provided basket market capitalisation data.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility, more stable returns, and closer tracking of broad market movements.
  • Treat as a core holding for portfolio stability rather than a speculative, high-growth trade.
  • Expect steady, long-term appreciation rather than explosive short-term gains; growth is likely moderate.
Total Market Cap
  • LMT: $113.27B

  • BA: $164.28B

  • XOM: $480.51B

  • Other

About This Group of Stocks

1

Our Expert Thinking

These companies aren't just spending on lobbying—they're making strategic investments to shape regulations in their favor. By creating favorable regulatory environments and securing subsidies, these firms build powerful competitive moats that can lead to consistent long-term profitability.

2

What You Need to Know

This collection includes established companies in heavily regulated sectors like defense, energy, finance, and pharmaceuticals. Their significant political spending indicates a deliberate strategy of using government relationships as a business advantage, potentially offering resilience against regulatory changes.

3

Why These Stocks

We've identified companies that consistently rank as top spenders on lobbying and political contributions. These selections are based on public data showing both the scale and consistency of their investment in political influence, highlighting a clear strategic focus.

Why You'll Want to Watch These Stocks

🗳️

Election Boost Coming

Major election cycles typically trigger increased corporate political spending as companies position themselves with potential new lawmakers. This could be a catalyst for many stocks in this collection.

🛡️

Regulatory Moat Advantage

These companies aren't just playing defense against regulations—they're actively shaping the rules of their industries. This creates lasting competitive advantages that more passive competitors simply can't match.

💼

Connected in All the Right Places

From defense contracts to energy policy and healthcare reforms, these companies have established strategic relationships with policymakers that can help them navigate changing political landscapes.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Streaming Consolidation (Netflix WBD Merger)

Streaming Consolidation (Netflix WBD Merger)

Netflix's proposed $72 billion acquisition of Warner Bros. Discovery signals a new era of massive consolidation in the entertainment sector. This theme focuses on other major media companies and content libraries that may now become attractive M&A targets as rivals race to compete at scale.

Oracle AI Data Centers Explained | $300B Project

Oracle AI Data Centers Explained | $300B Project

Oracle's massive $300 billion data center project for OpenAI highlights the intense demand for physical AI infrastructure. This theme invests in the "picks and shovels" companies providing essential components like power management, cooling systems, and high-speed networking required for this construction boom.

Personal Care Stocks | Talc Lawsuit Impact on Market

Personal Care Stocks | Talc Lawsuit Impact on Market

A jury has ordered Johnson & Johnson to pay $40 million in a lawsuit linking its talc-based powder to ovarian cancer, adding to its significant legal challenges. This ongoing litigation creates an opportunity for competitors offering safer, talc-free personal care alternatives to gain market share.

Frequently Asked Questions